282 related articles for article (PubMed ID: 16381776)
1. Measurements of secondary neutron dose from 15 MV and 18 MV IMRT.
Howell RM; Ferenci MS; Hertel NE; Fullerton GD; Fox T; Davis LW
Radiat Prot Dosimetry; 2005; 115(1-4):508-12. PubMed ID: 16381776
[TBL] [Abstract][Full Text] [Related]
2. Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator.
Vanhavere F; Huyskens D; Struelens L
Radiat Prot Dosimetry; 2004; 110(1-4):607-12. PubMed ID: 15353716
[TBL] [Abstract][Full Text] [Related]
3. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
[TBL] [Abstract][Full Text] [Related]
4. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of neutron fields around high-energy x-ray radiotherapy machines.
Králík M; Turek K
Radiat Prot Dosimetry; 2004; 110(1-4):503-7. PubMed ID: 15353699
[TBL] [Abstract][Full Text] [Related]
6. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.
Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1204-16. PubMed ID: 15990026
[TBL] [Abstract][Full Text] [Related]
7. Experimental determination of peripheral doses for different IMRT techniques delivered by a Siemens linear accelerator.
Wiezorek T; Voigt A; Metzger N; Georg D; Schwedas M; Salz H; Wendt TG
Strahlenther Onkol; 2008 Feb; 184(2):73-9. PubMed ID: 18259698
[TBL] [Abstract][Full Text] [Related]
8. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
Reft CS; Runkel-Muller R; Myrianthopoulos L
Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
[TBL] [Abstract][Full Text] [Related]
9. Peripheral dose in ocular treatments with CyberKnife and Gamma Knife radiosurgery compared to proton radiotherapy.
Zytkovicz A; Daftari I; Phillips TL; Chuang CF; Verhey L; Petti PL
Phys Med Biol; 2007 Oct; 52(19):5957-71. PubMed ID: 17881812
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
11. Determination of absorbed dose in the vicinity of a neutron source.
Schlegel DR
Radiat Prot Dosimetry; 2004; 110(1-4):819-21. PubMed ID: 15353752
[TBL] [Abstract][Full Text] [Related]
12. Study on surface dose generated in prostate intensity-modulated radiation therapy treatment.
Chow JC; Grigorov GN; Barnett RB
Med Dosim; 2006; 31(4):249-58. PubMed ID: 17134664
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric considerations on TEPC fluka-simulation and measurements.
Rollet S; Beck P; Ferrari A; Pelliccioni M; Autischer M
Radiat Prot Dosimetry; 2004; 110(1-4):833-7. PubMed ID: 15353755
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the neutron contamination in IMRT deliveries with a paired magnesium and boron coated magnesium ionization chamber system.
Becker J; Brunckhorst E; Schmidt R
Radiother Oncol; 2008 Feb; 86(2):182-6. PubMed ID: 18023490
[TBL] [Abstract][Full Text] [Related]
15. Neutron fluence-to-dose conversion coefficients for embryo and fetus.
Chen J; Meyerhof D; Vlahovich S
Radiat Prot Dosimetry; 2004; 110(1-4):693-8. PubMed ID: 15353732
[TBL] [Abstract][Full Text] [Related]
16. Incidental testicular irradiation from prostate IMRT: it all adds up.
King CR; Maxim PG; Hsu A; Kapp DS
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):484-9. PubMed ID: 19733013
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of 60Co intensity-modulated radiation therapy.
Fox C; Romeijn HE; Lynch B; Men C; Aleman DM; Dempsey JF
Phys Med Biol; 2008 Jun; 53(12):3175-88. PubMed ID: 18506074
[TBL] [Abstract][Full Text] [Related]
18. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
19. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
Hong TS; Tomé WA; Jaradat H; Raisbeck BM; Ritter MA
Acta Oncol; 2006; 45(6):717-27. PubMed ID: 16938815
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
